![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07K 14/505 | (2006.01) |
C07K 14/555 | (2006.01) | ||
C07K 14/56 | (2006.01) | ||
C07K 14/565 | (2006.01) | ||
C07K 14/745 | (2006.01) | ||
C07K 14/475 | (2006.01) | ||
C07K 16/00 | (2006.01) | ||
C12N 9/64 | (2006.01) | ||
C12N 9/96 | (2006.01) | ||
A61K 47/48 | (2006.01) |
(11) | Number of the document | 2361932 |
(13) | Kind of document | T |
(96) | European patent application number | 10182890.3 |
Date of filing the European patent application | 2004-05-06 | |
(97) | Date of publication of the European application | 2011-08-31 |
(45) | Date of publication and mention of the grant of the patent | 2016-05-04 |
(46) | Date of publication of the claims translation | 2016-07-25 |
(30) | Number | Date | Country code |
469600 P | 2003-05-06 | US | |
487964 P | 2003-07-17 | US | |
539207 P | 2004-01-26 | US |
(72) |
Peters, Robert T., US
Mezo, Adam R, US
Rivera, Daniel S, US
Bitonti, Alan J, US
Stattel, James M, US
Low, Susan C, US
|
(73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
(74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Imunoglobulino chimeriniai monomeriniai-dimeriniai hibridai |
IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS |
Payment date | Validity (years) | Amount | |
2022-04-15 | 19 | 347.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2023-05-06 |